Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 03 Jan 2023 07:00 CET |
ARGENX SE | argenx to Present at 41st Annual J.P. Morgan Healthcare Conference | 20103010 Biotechnology | Other subject |
| 12 Dec 2022 22:01 CET |
ARGENX SE | argenx Appoints Ana Cespedes to Board of Directors | 20103010 Biotechnology | Other subject |
| 10 Dec 2022 17:30 CET |
ARGENX SE | argenx to Present Pivotal ADVANCE Trial Data During ASH Plenary Session Highlighting VYVGART® (efgartigimod alfa-fcab) as Potential New Treatment Modality for Immune Thrombocytopenia | 20103010 Biotechnology | Other subject |